BioCentury
ARTICLE | Finance

Two-way crossing

Shanghai’s Lyfe Capital to leverage cross-border networks with second fund

June 9, 2017 5:14 PM UTC

Lyfe Capital’s second fund seeks to expand on the cross-border activity of its first. In addition to investing in Chinese companies that can benefit from the VC’s U.S. and European network, Lyfe Capital Fund II also will invest in a handful of U.S. companies that it can connect with its network in China.

Fund II closed on May 29 with about $420 million, including $288.8 million and RMB900 million ($131.3 million). About 20% will be allocated to U.S. companies. ...